Skip to content

Changes in specific antibody titers and interferon gamma levels after an Omicron BA.4/BA.5-Adapted Bivalent Booster

Changes in specific antibody titers and interferon gamma levels after an Omicron BA.4/BA.5-Adapted Bivalent Booster - Changes in specific antibody titers and interferon gamma levels after an Omicron BA.4/BA.5-Adapted Bivalent Booster

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000049273
Enrollment
150
Registered
2022-11-10
Start date
2022-10-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Sponsors

Fukuoka City Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Employees of Fukuoka City Hospital who have been measured spike-specific antibody titers and interferon gamma levels.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Changes in spike-specific antibody titers and interferon gamma levels one month after an Omicron BA.4/BA.5-Adapted Bivalent Booster.

Secondary

MeasureTime frame
The relation between the degree of adverse reactions and the strength of the immune response to an Omicron BA.4/BA.5-Adapted Bivalent Booster.

Countries

Japan

Contacts

Public ContactNaoki Tani

Kyushu University Graduate School of Medical Sciences Medicine and Biosystemic Science

tani.kyushu.univ@gmail.com+81-92-642-5229

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026